{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:29:50Z","timestamp":1783178990697,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bioorg.2019.103130","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T10:20:00Z","timestamp":1563618000000},"page":"103130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors"],"prefix":"10.1016","volume":"91","author":[{"given":"Niccol\u00f2","family":"Chiaramonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ferraroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Picchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Braconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Dei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Teodori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Novella","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103130_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41396-019-0426-8","article-title":"A new widespread subclass of carbonic anhydrase in marine phytoplankton","author":"Jensen","year":"2019","journal-title":"ISME J."},{"key":"10.1016\/j.bioorg.2019.103130_b0010","series-title":"Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications","year":"2014"},{"issue":"8","key":"10.1016\/j.bioorg.2019.103130_b0015","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"issue":"10","key":"10.1016\/j.bioorg.2019.103130_b0020","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/13543776.2018.1519023","article-title":"Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103130_b0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737175.2016.1193009","article-title":"Carbonic anhydrase inhibition and the management of neuropathic pain","volume":"16","author":"Supuran","year":"2016","journal-title":"Expert Rev. Neurother."},{"issue":"12","key":"10.1016\/j.bioorg.2019.103130_b0030","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.bioorg.2019.103130_b0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.bioorg.2019.103130_b0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2019.103130_b0045","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1016\/j.bmc.2015.07.024","article-title":"Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties","volume":"23","author":"Congiu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2019.103130_b0050","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.bmcl.2015.07.060","article-title":"Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity","volume":"25","author":"Congiu","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103130_b0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bioorg.2017.12.034","article-title":"Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action","volume":"77","author":"Havr\u00e1nkov\u00e1","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2019.103130_b0060","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1021\/acs.jmedchem.6b01804","article-title":"Discovery of benzenesulfonamides with potent human carbonic anhydrase inhibitory and effective anticonvulsant action: design, synthesis, and pharmacological assessment","volume":"60","author":"Mishra","year":"2017","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2019.103130_b0065","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1021\/acs.jmedchem.8b00208","article-title":"Discovery of benzenesulfonamide derivatives as carbonic anhydrase inhibitors with effective anticonvulsant action: design, synthesis, and pharmacological evaluation","volume":"61","author":"Mishra","year":"2018","journal-title":"J. Med. Chem."},{"issue":"Supplement C","key":"10.1016\/j.bioorg.2019.103130_b0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejmech.2013.09.027","article-title":"Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII","volume":"69","author":"S\u0142awi\u0144ski","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103130_b0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/14756366.2017.1413097","article-title":"Inhibition studies of Brucella suis \u03b2-carbonic anhydrases with a series of 4-substituted pyridine-3-sulphonamides","volume":"33","author":"Monti","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103130_b0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ejmech.2018.11.073","article-title":"Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety","volume":"163","author":"Buemi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103130_b0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejmech.2018.04.002","article-title":"2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents","volume":"151","author":"Chiaramonte","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103130_b0090","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1039\/b301502e","article-title":"Preparation of diamines by lithiation\u2013substitution of imidazolidines and pyrimidines","volume":"1","author":"Ashweek","year":"2003","journal-title":"Org. Biomol. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2019.103130_b0095","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/j.bmcl.2016.04.086","article-title":"Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria","volume":"26","author":"Lee","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103130_b0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejmech.2015.12.010","article-title":"Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization","volume":"109","author":"Obreque-Balboa","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103130_b0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bmc.2013.12.050","article-title":"Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-\u03b2-hydroxysteroid dehydrogenase (AKR1C3)","volume":"22","author":"Flanagan","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2019.103130_b0110","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1021\/jm900553j","article-title":"Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo","volume":"52","author":"Perez","year":"2009","journal-title":"J. Med. Chem."},{"issue":"51","key":"10.1016\/j.bioorg.2019.103130_b0115","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1016\/j.tet.2007.09.075","article-title":"Synthesis of an indole containing KDR kinase inhibitor by tandem Sonogashira coupling-5-endo-dig-cyclization as a key step","volume":"63","author":"Palimkar","year":"2007","journal-title":"Tetrahedron"},{"issue":"12","key":"10.1016\/j.bioorg.2019.103130_b0120","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1021\/ja00091a005","article-title":"Lack of effect of the length of oligoglycine- and oligo(ethylene glycol)-derived para-substituents on the affinity of benzenesulfonamides for carbonic anhydrase II in solution","volume":"116","author":"Jain","year":"1994","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103130_b0125","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bmcl.2009.01.012","article-title":"The design and discovery of novel amide CCR5 antagonists","volume":"19","author":"Pryde","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103130_b0130","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.103130_b0135","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bioorg.2018.09.028","article-title":"Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism","volume":"81","author":"Angeli","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103130_b0140","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ejmech.2018.08.096","article-title":"Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity","volume":"157","author":"Angeli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103130_b0145","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acsmedchemlett.8b00076","article-title":"Design, synthesis, and X-ray of selenides as new class of agents for prevention of diabetic cerebrovascular pathology","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103130_b0150","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.anchem.1.031207.112945","article-title":"High-resolution mass spectrometers","volume":"1","author":"Marshall","year":"2008","journal-title":"Annu. Rev. Anal. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2019.103130_b0155","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1021\/jm000296j","article-title":"Carbonic anhydrase inhibitors: perfluoroalkyl\/aryl-substituted derivatives of aromatic\/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action","volume":"43","author":"Scozzafava","year":"2000","journal-title":"J. Med. Chem."},{"issue":"40","key":"10.1016\/j.bioorg.2019.103130_b0160","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1002\/anie.200701189","article-title":"Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste","volume":"46","author":"K\u00f6hler","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2019.103130_b0165","series-title":"Evolving Methods for Macromolecular Crystallography: The Structural Path to the Understanding of the Mechanismof Action of CBRN Agents","first-page":"41","article-title":"Processing diffraction data with mosflm","author":"Leslie","year":"2007"},{"issue":"3","key":"10.1016\/j.bioorg.2019.103130_b0170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Cryst. D"},{"issue":"4","key":"10.1016\/j.bioorg.2019.103130_b0175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1107\/S090744491200251X","article-title":"JLigand: a graphical tool for the CCP4 template-restraint library","volume":"68","author":"Lebedev","year":"2012","journal-title":"Acta Cryst. D"},{"issue":"4","key":"10.1016\/j.bioorg.2019.103130_b0180","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Cryst. D"},{"key":"10.1016\/j.bioorg.2019.103130_b0185","series-title":"International Tables for Crystallography. Vol. F: Crystallography of Biological Macromolecules","first-page":"720","article-title":"The ARP\/wARP suite for automated construction and refinement of protein models","author":"Lamzin","year":"2001"},{"issue":"3","key":"10.1016\/j.bioorg.2019.103130_b0190","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"issue":"13","key":"10.1016\/j.bioorg.2019.103130_b0195","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819309319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819309319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:52:05Z","timestamp":1758613925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819309319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":39,"alternative-id":["S0045206819309319"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103130","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103130"}}